Filed under: Africa, Bureaucracy, Freedom, Health Care, Heartwarming, Regulation, Science/Technology | Tags: A New Vaccine, Conquering Ebola, Public Health Bureaucracy
How about a little good news for a change? An invention has come along that has changed the landscape completely.
A vaccine invented in Canada was tested in a large scale inoculation in Guinea and Sierra Leone by the World Health Organization to assess just how well it protected people against Ebola—the dreadful virus that ravaged Africa in 2014, killing 60 percent of the people who were infected. What happened? It succeeded spectacularly. It protected 100 percent of the people who received it. This is the first and only therapy for Ebola other than the previous supportive measures.
The vaccine, which is a glycoprotein (1) called rVSV-ZEBOV, was tested in Guinea and Sierra Leone. The group gathered samples from an individual, either alive or dead who had a positive lab test for Ebola, and then identified a cluster of their contacts, contacts of the contacts, and the contacts of the contacts who weren’t around when the team arrived. Each uninfected person got a single injection of the vaccine in the arm. The results are stunning.
The group identified a total of 4539 people in 51 clusters between March 2015, and January 2016. About half (2119 people) received the vaccine immediately, and another 2041 got it 21 days later.
The name of the vaccine sounds daunting, but it’s really not. The “r” means recombinant—formed by alteration of viral DNA, which can be done using standard molecular biotechnology techniques. VSV stands for vesicular stomatitis virus—the virus that was modified (2). ZEBOV is short for Zaire Ebola virus, which was the most deadly circulating strain.
This is a very big deal. The safety profile is excellent, and only two adverse effects were attributed to the vaccine itself. It is an enormous achievement, and could rid the world of a very scary, very dangerous disease.
The epidemic in 2014-15 claimed the lives of 11,300 people in West Africa, spread the virus as far as New York and Texas, and demonstrated the failures of the world public health system.”The public health bureaucracy resists therapeutics, which threaten traditional manpower-heavy quarantines and tracking.” By 2015, cases were low and declining and researchers were able to gather real world information on an accelerated schedule. The study was so successful that it was stopped early since not providing the vaccine to the control group was unethical.
Ebola is a complex and mutating pathogen, and no scientific triumph is ever final. But the public-health bureaucracy demonstrated no such humility, and its overconfidence showed how unprepared the world is to respond to biological threats. Developing and deploying more vaccines like rVSV-Zebov may be the best defense.